Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7.Diabetes Care. 2013; 36: 908-913
Latent autoimmune diabetes in adults (LADA) should be less latent.Diabetologia. 2005; 48: 2206-2212
Diabetes classification: grey zones, sound and smoke: Action LADA 1.Diabetes Metab Res Rev. 2008; 24: 511-519
- Naik R.G.
- Brooks-Worrell B.M.
- Palmer J.P.
Latent autoimmune diabetes in adults.J Clin Endocrinol Metab. 2009; 94: 4635-4644
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.Diabetes. 1999; 48: 150-157
- Grant S.F.
- Hakonarson H.
- Schwartz S.
Can the genetics of type 1 and type 2 diabetes shed light on the genetics of latent autoimmune diabetes in adults?.Endocr Rev. 2010; 31: 183-193
- Carlsson S.
- Midthjell K.
- Grill V.
Influence of family history of diabetes on incidence and prevalence of latent autoimmune diabetes of the adult: results from the Nord-Trondelag Health Study.Diabetes Care. 2007; 30: 3040-3045
Metabolic syndrome and autoimmune diabetes: action LADA 3.Diabetes Care. 2009; 32: 160-164
Age, overweight and physical inactivity increase the risk of latent autoimmune diabetes in adults: results from the Nord-Trondelag health study.Diabetologia. 2007; 50: 55-58
Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes.BMC Med. 2017; 15: 88
The type 2 diabetes-associated variant in TCF7L2 is associated with latent autoimmune diabetes in adult Europeans and the gene effect is modified by obesity: a meta-analysis and an individual study.Diabetologia. 2012; 55: 689-693
Twenty-year progression rate to clinical onset according to autoantibody profile, age, and HLA-DQ genotype in a registry-based group of children and adults with a first-degree relative with type 1 diabetes.Diabetes Care. 2017; 40: 1065-1072
Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults.Diabetes Care. 2008; 31: 439-441
Latent autoimmune diabetes in adults: a guide for the perplexed.Diabetologia. 2005; 48: 2195-2199
Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients.Diabetes. 2009; 58: 738-744
Autoimmunity and clinical course in children with type 1, type 2, and type 1.5 diabetes.J Autoimmun. 2005; 25: 244-250
- Jones A.G.
- Hattersley A.T.
The clinical utility of C-peptide measurement in the care of patients with diabetes.Diabet Med. 2013; 30: 803-817
Variation of C peptide decay rate in diabetic patients with positive glutamic acid decarboxylase antibody: better discrimination with initial fasting C peptide.BMC Endocr Disord. 2013; 13: 10
Levels of C-peptide, body mass index and age, and their usefulness in classification of diabetes in relation to autoimmunity, in adults with newly diagnosed diabetes in Kronoberg, Sweden.Eur J Endocrinol. 2012; 166: 1021-1029
Interventions for latent autoimmune diabetes (LADA) in adults.Cochrane Database Syst Rev. 2007; : CD006165
Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe.Diabetes. 2004; 53: 3193-3200
Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain.Diabetes Metab Res Rev. 2013; 29: 446-451
High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.Diabetes Care. 2007; 30: 932-938
Mortality in adult-onset autoimmune diabetes is associated with poor glycemic control: results from the HUNT Study.Diabetes Care. 2013; 36: 3971-3978
Comparison of clinical and laboratory characteristics between adult-onset type 1 diabetes and latent autoimmune diabetes in adults.Diabetes Care. 2005; 28: 1803-1804
Worse glycaemic control in LADA patients than in those with type 2 diabetes, despite a longer time on insulin therapy.Diabetologia. 2013; 56: 252-258
Latent autoimmune diabetes in adults (LADA) in South Wales: incidence and characterization.Diabet Med. 2008; 25: 1354-1357
New approaches beyond genetics: towards precision medicine in diabetes.Diabetologia. 2016; 59: 2495-2496
Differentiation of diabetes by pathophysiology, natural history, and prognosis.Diabetes. 2017; 66: 241-255
Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables.Diabetes Care. 1988; 11: 531-537
Two-site time-resolved immunofluorometric assay of human insulin.Clin Chem. 1986; 32: 637-640
Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis (2 edn).2nd ed. Springer,
Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression.Diabetes Care. 2003; 26: 452-457
Metabolite profiling of LADA challenges the view of a metabolically distinct subtype.Diabetes. 2017; 66: 806-814
Presence of anti-GAD in a non-diabetic population of adults; time dynamics and clinical influence: results from the HUNT study.BMJ Open Diabetes Res Care. 2015; 3: e000076
Heterogeneity of patients with latent autoimmune diabetes in adults: linkage to autoimmunity is apparent only in those with perceived need for insulin treatment: results from the Nord-Trondelag Health (HUNT) study.Diabetes Care. 2009; 32: 245-250
Common variants in the TCF7L2 gene help to differentiate autoimmune from non-autoimmune diabetes in young (15–34 years) but not in middle-aged (40–59 years) diabetic patients.Diabetologia. 2008; 51: 2224-2232
- Rolandsson O.
- Palmer J.P.
Latent autoimmune diabetes in adults (LADA) is dead: long live autoimmune diabetes!.Diabetologia. 2010; 53: 1250-1253
Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus.J Clin Endocrinol Metab. 2008; 93: 2115-2121
Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM.Diabetes. 1996; 45: 622-626
Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes.Diabetologia. 1989; 32: 305-311
Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus.Diabetologia. 1990; 33: 561-568
Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents.Lancet. 1977; 1: 1025-1027
Development of type 2 diabetes mellitus in the obese adolescent: a growing challenge.Endocr Pract. 2012; 18: 791-795
Intensive lifestyle intervention in type 2 diabetes.N Engl J Med. 2013; 369: 2358-2359